Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
675 studies found for:    Open Studies | "Hemorrhage"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hemorrhage" (675 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Safety and Effectiveness of the InPress Device in Treating Primary Postpartum Hemorrhage
Condition: Postpartum Hemorrhage
Intervention: Device: InPress Device
2 Recruiting Tampostat for Management of Postpartum Hemorrhage
Condition: Postpartum Hemorrhage
Interventions: Device: Tampostat;   Device: Condom catheter tamponade
3 Not yet recruiting Amr's Maneuver and Postpartum Hemorrhage
Condition: Postpartum Hemorrhage
Intervention: Procedure: Amr maneuver
4 Recruiting Conbercept Injection in Treatment of Vitreous Hemorrhage
Condition: Vitreous Hemorrhage
Intervention: Drug: Conbercept
5 Not yet recruiting Intrauterine Tamponade With a Belfort-Dildy Balloon in the Treatment of Severe Immediate Postpartum Hemorrhage
Condition: Immediate Postpartum Hemorrhage
Intervention: Device: Belfort-Dildy Balloon
6 Recruiting Observational Study of Patients With Subarachnoid Hemorrhage
Condition: Subarachnoid Hemorrhage
Intervention:
7 Recruiting Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial
Condition: Intracerebral Hemorrhage
Interventions: Drug: Deferoxamine Mesylate;   Drug: Placebo (for Deferoxamine Mesylate)
8 Not yet recruiting Safety and Tolerability of PF-05230907 in Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage (ICH)
Intervention: Biological: PF-05230907
9 Recruiting Decompressive Hemicraniectomy in Intracerebral Hemorrhage
Condition: Cerebral Hemorrhage
Interventions: Procedure: Decompressive craniectomy (DC) and best medical treatment;   Procedure: Best medical treatment
10 Recruiting Tranexamic Acid for Preventing Postpartum Haemorrhage Following a Vaginal Delivery
Condition: Immediate Postpartum Hemorrhage
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
11 Recruiting Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Interventions: Drug: deferoxamine;   Drug: Xingnaojing injection;   Drug: Normal saline
12 Recruiting A Pilot Study of Minocycline in Intracerebral Hemorrhage Patients
Condition: Intracerebral Hemorrhage
Intervention: Drug: Minocycline
13 Recruiting Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.
Condition: Subarachnoid Hemorrhage
Intervention: Drug: Tranexamic Acid
14 Recruiting Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
Condition: Post Partum Hemorrhage
Interventions: Drug: Ergometrine;   Drug: Oxytocin
15 Not yet recruiting Etiology and Prognostic Risk Factors of Intracerebral Hemorrhage in Beijing
Condition: Intracerebral Hemorrhage
Intervention: Device: CT Angiography
16 Recruiting Predictive Values of Serum Adiponectin Levels in Aneurysmal Subarachnoid Hemorrhage.
Condition: Subarachnoid Hemorrhage, Aneurysmal
Intervention:
17 Recruiting Coagulation Factors and Postpartum Hemorrhage
Condition: Postpartum Hemorrhage
Intervention: Other: blood exam
18 Not yet recruiting INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo in Patients With Brain Hemorrhage
Condition: Intracranial Hemorrhage
Intervention: Device: Apollo MIES
19 Not yet recruiting INVEST: Minimally Invasive Endoscopic Surgery vs. Medical Management in Supratentorial Intraparenchymal Hemorrhage
Condition: Intracranial Hemorrhage
Interventions: Device: Apollo MIES;   Other: Medical Management
20 Recruiting Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Condition: Subarachnoid Hemorrhage, Aneurysmal
Interventions: Drug: EG-1962 (nimodipine microparticles);   Drug: Enteral Nimodipine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.